Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
Seizure-spotting headset maker Ceribell seeks $101M Nasdaq IPO
The former Fierce 15 winner has priced some 6.7 million shares in the range of $14 to $16, for a proposed total market value of about $505.4 million.
Conor Hale
Oct 7, 2024 11:30am
MARAbio’s antibody test for autoimmune-related autism nets $19M
Oct 7, 2024 10:00am
FDA approves Exact Sciences’ next-gen Cologuard Plus home test
Oct 4, 2024 12:30pm
Proscia launches pathology toolkits for building AI models
Oct 3, 2024 1:45pm
Siemens Healthineers scores FDA nod for 5-second, 3D mammography
Oct 3, 2024 11:30am
GE HealthCare's PET tracer for heart disease nets FDA approval
Oct 1, 2024 12:00pm
